TESTIM

This brand name is authorized in Canada, Estonia, Ireland, Lithuania, United Kingdom, United States

Active ingredients

The drug TESTIM contains one active pharmaceutical ingredient (API):

1 Testosterone UNII 3XMK78S47O - TESTOSTERONE

Testosterone, secreted by the testes and its major metabolite dihydrotestosterone (DHT), is responsible for the development of the external and internal genital organs and for maintaining the secondary sexual characteristics (stimulating hair growth, deepening of the voice, development of the libido); for a general effect on protein anabolism; for development of skeletal muscle and body fat distribution; for a reduction in urinary nitrogen, sodium, potassium, chloride, phosphate and water excretion. Read about Testosterone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TESTIM Transdermal Gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03BA03	Testosterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03B Androgens → G03BA 3-oxoandrosten (4) derivatives
Discover more medicines within G03BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02280248
Country: EE	Ravimiamet	Identifier(s): 1554993, 1555185, 1555196, 1555208
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 91816
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1064754, 1069198, 1069199, 1069200
Country: US	FDA, National Drug Code	Identifier(s): 66887-001